GPC3 and breast cancer: In contrast, glypican-3 inhibits the advance of BC and metastasis precisely by affecting the Wnt/β-catenin signalling pathways, too [97], which is rather challenging, as the activation of the non-canonical Wnt pathway concomitantly to the de-activation of the canonical Wnt pathway was also found in glypican-3.